Oct 07 2024
Runtz.
Using data from various state regulatory agencies, as well as data from sites that track strain popularity such as Leafly, here are the five marijuana strains dominating sales as of October 2024. Continue reading
Oct 07 2024
Within these sales, $12.5 million was attributed to “usable cannabis,” $5.6 million to marijuana concentrates, and $3.1 million to “infused products.”
With September’s sales, the year-to-date total has reached an impressive $183,209,598 from 3,406,206 transactions, according to the Maine Office of Cannabis Policy.
Continue reading
Oct 07 2024
The SNS Insider report indicates that the market is valued at $2.29 billion in 2023, and is projected to reach $22 billion by 2032 with a remarkable CAGR (compound annual growth rate) of 28.7% over the forecast period from 2024 to 2032.”
“The CBD skincare product market is very promising and growing with the fact that people today are desperately looking for natural and organic ingredients in personal care products”, states the report. “Consumers prefer products that offer therapeutic benefits without chemicals that can have adverse impacts.”
Continue reading
Oct 07 2024
Researchers from the University of Southern California, Brandeis University, and Monash University in Australia analyzed data from over 16,000 patients who purchased medical cannabis from dispensaries in New York over a four year period. The study sought to better understand patterns in the consumption of Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) over time.
Using purchase data recorded in point-of-sale systems, the researchers identified six distinct patterns of cannabis dosing. For THC, the majority of patients (62.6%) maintained steady doses at either low (4.1 mg) or moderate levels (7.4 mg). Approximately 22% of patients exhibited fluctuating or increasing THC doses over time, ranging from 5 to 20 mg. A smaller group, making up 15.8% of the total, decreased their THC intake from 11 mg to 5 mg over the study period. Similar patterns were observed for CBD, though the dosing levels tended to be higher, ranging between 4 and 16 mg.
Continue reading
Oct 07 2024
These unique compounds, distinct from traditional cannabinoids, have shown remarkable effectiveness in combating drug-resistant Candida species, notes the study’s researchers. Published in Pharmacological Research, the study reveals how these derivatives not only inhibit fungal growth but also disrupt biofilm formation, offering a promising new approach to battling antifungal resistance.
The research was conducted by scientists from the University of Jerusalem, Ariel University, and The Hebrew University of Jerusalem. Their work focused on abnormal cannabinoids, a class of synthetic lipid compounds that, unlike traditional cannabinoids, do not interact with CB1 and CB2 receptors. Previous studies highlighted the cardioprotective and anti-inflammatory properties of one compound in particular, comp 3, as well as its antimicrobial potential against methicillin-resistant Staphylococcus aureus (MRSA).
Continue reading
Oct 07 2024
The collaboration includes the Pakistan National University of Sciences and Technology, the University of the Punjab, and The Islamia University of Bahawalpur, along with international partners from the Polytechnic Institute of Bragança, Fırat University, Shaqra University, and Korea University. The study was also published online by the US National Library of Medicine.
Cannabinoids, known for centuries in traditional medicine, are gaining renewed attention for their therapeutic properties, particularly in cancer care. The study highlights how compounds like Δ9-THC, CBD, and CBG show promising effects in fighting cancer by influencing critical cellular processes such as inducing apoptosis (programmed cell death), stimulating autophagy (cell cleanup), and inhibiting metastasis and angiogenesis (tumor growth through blood vessel formation). These findings are based on an extensive review of literature from databases like PubMed, Google Scholar, Web of Science, Scopus, and Embase.
Continue reading
Oct 07 2024
On October 1, Congressmember Amu Bera (D-CA) became the latest lawmaker to join as a sponsor for the SAFE Banking Act (H.R. 2891). The measure now has 131 bipartisan sponsors, more than any other marijuana-related bill in the U.S. Congress.
The SAFE Banking Act is designed to establish federal protections for banks and credit unions that work with marijuana businesses operating legally under state law. This applies to thousands of dispensaries and retail outlets across the 38 states with medical marijuana programs, as well as the 23 states that allow recreational sales. The bill would also allow these businesses to take standard IRS tax deductions, which they are currently denied.
Continue reading
Oct 05 2024
Approximately 85% of these sales were made by recreational consumers, while medical marijuana purchases accounted for 15% of the total. Nearly one in four recreational marijuana purchases was made by non-residents, with Illinois residents responsible for around 77% of the sales.
Year-to-date, marijuana sales in Illinois have surpassed $1.5 billion, generating over $275 million in tax revenue.
Continue reading
Oct 04 2024
Recreational marijuana sales began in Ohio on August 6. Between that day and September 28, the state’s Division of Cannabis Control reported total sales of $87.1 million. During that period, recreational retailers sold 10,213 pounds of flower and 1,361,146 units of manufactured products.
During the same period, medical marijuana patients purchased $52,047,919 worth of product, bringing the combined total for legal marijuana sales between August 6 and September 28 to $139,171,008.
Continue reading
Oct 04 2024
According to data released by the research firm Headset, there was $97.4 million worth of marijuana and marijuana products sold legally in September. Although this is a drop from the record-breaking $100.6 million sold in August, it marks a nearly 5% increase from sales total from the previous September.
The year-to-date total for marijuana sales in Maryland is now approximately $850 million.
Continue reading
